Conviction
$ Value
$78K
Shares
4,422
Price
$18
Filed
Feb 20
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Pavlov George
Title
—
CIK
0001470798
Roles
Transaction Details
Transaction Date
2026-02-19
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
15,080
Footnotes
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.22 to $17.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.28 to $17.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.74 to $17.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
Pavlov George's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-20 | MPLT | ▲ | $177K |
| 2026-02-19 | MPLT | ▲ | $78K |
| 2026-02-18 | MPLT | ▲ | $186K ★ |
Other Insiders at MPLT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Pavlov George | $363K | — | 2026-02-20 |
| Garnett Timothy John | $253K | — | 2026-02-10 |
|
Kroeger Christopher A.
Chief Executive Officer
|
— | $521K | 2026-04-16 |
|
GILLIS JONATHAN
CAAO and PAO
|
— | $96K | 2026-04-15 |
|
Lillie James Woodruff
Chief Scientific Officer
|
— | $123K | 2026-04-16 |
|
Hanson Kristopher
General Counsel
|
— | $49K | 2026-04-16 |
| Malenka Robert C. | — | $1.6M | 2026-04-15 |
|
Foff Erin Pennock
Chief Medical Officer
|
— | $87K | 2026-04-16 |
|
Kreitzer Anatol
Chief Discovery Officer
|
— | $88K | 2026-04-15 |
|
Setia Vishwas
Chief Financial Officer
|
— | $79K | 2026-04-16 |